作者: Inbal Avraham-Davidi , Karina Yaniv , Yogev Sela
DOI:
关键词: Internal medicine 、 Angiogenesis 、 Endocrinology 、 Medicine 、 Apolipoprotein B 、 Pharmacology
摘要: A method of treating an angiogenesis related disease or disorder in a subject need thereof is disclosed. The comprises administering to the therapeutically effective amount agent which regulates apolipoprotein B (ApoB), and/or ability ApoB transcriptionally control vascular endothelial growth factor receptor 1 (VEGFR1).